期刊文献+

脂蛋白相关磷脂酶A2表达与动脉粥样硬化进程相关性研究 被引量:7

Study on relationship of lipoprotein-associated phospholipase A2 expression and atherosclerosis progression
下载PDF
导出
摘要 目的利用ApoE基因缺陷小鼠建立动脉粥样硬化(AS)模型,研究AS进展过程中脂蛋白相关磷脂酶A2(Lp-PLA2)水平的变化及其在血管组织中的分布,并比较Lp-PLA2及其他生物标志物与AS的相关性。方法将已敲除Apo E基因的小鼠随机分为两组,对照组饲以一般饲料,实验组饲以高脂饮食,建立AS模型。定期取小鼠血清测定Lp-PLA2及其他血脂、炎症指标,并取主动脉染色做抗Lp-PLA2免疫组织化学染色。结果实验组Lp-PLA2明显高于对照组(P<0.05),Lp-PLA2与周龄呈显著的线性相关。多因素分析所得回归方程为Y=0.767778xLp-PLA2+0.000594xTG(r^2=0.89658),此方程可用于评估AS进展程度。Lp-PLA2随AS病程发展在斑块内表达逐渐增多,主要分布在脂质核中心以及巨噬细胞富集的区域;AS中后期Lp-PLA2大量分布在变薄的纤维帽下。结论与传统风险因子相比,Lp-PLA2与AS的相关性更好,与AS斑块不稳定性相关,可以用于评估AS进展程度。 Objective We established atherosclerosis(AS)animal model to study the tendency of lipoprotein-associated phospholipase A2(Lp-PLA2)variation,and distribution of Lp-PLA2 in vascular tissues.Methods ApoE-deficient mice were randomly divided into two groups,of which control group fed on chow diet,the experimental group fed on high fat diet.Mice were randomly picked up to determine serum Lp-PLA2 and other biomarkers,and the aortas were dissected to be immunohistochemically stained with anti-Lp-PLA2.Results Lp-PLA2 levels in the experimental group were significantly higher than those in control group(P<0.05).There was also significantly linear correlation between Lp-PLA2 and week-of-birth.Multiple factors analysis showed the equation was Y=0.767778xLp-PLA2+0.000594xTG(r2=0.89658),which could be used to estimate the progression of cardiovascular and cerebrovascular disease.The results from immunohistochemical staining indicated that early plaque had much less Lp-PLA2 than expanded plaques did.Lp-PLA2 mainly distributed in necrotic cores and around the macrophages.At later stage,a large number of Lp-PLA2 was located under the thinning fibrous cap.Conclusion Compared to traditional risk factors,Lp-PLA2 showes greater relevance to AS,and is also related to plaque vulnerability.
作者 黄立纲 刘炼华 刘航齐 贾玫 HUANG Li-gang;LIU Lian-hua;LIU Hang-qi;JIA Mei(Deparment of Laboratory Medicine,Peking University People′s Hospital,Beijing 100044,China)
出处 《中国医药生物技术》 2018年第2期151-156,共6页 Chinese Medicinal Biotechnology
关键词 1-烷基-2-乙酰甘油磷酸胆碱酯酶 载脂蛋白E类 动脉粥样硬化 心血管疾病 1-alkyl-2-acetylglycerophosphocholine esterase Apolipoprotein E Atherosclerosis Cardiovascular disease
  • 相关文献

参考文献4

二级参考文献41

  • 1张春妮,汪俊军,庄一义,刘小传,强宏娟,陈大宁.脂蛋白对巨噬细胞的作用研究进展[J].中国动脉硬化杂志,2005,13(2):225-227. 被引量:3
  • 2范乐明.动脉粥样硬化炎症机制的再认识[J].中国动脉硬化杂志,2005,13(3):249-253. 被引量:73
  • 3J Am Coll Cardiol,张伟丽.CRP与斑块破裂有关[J].中国分子心脏病学杂志,2005,5(3):546-546. 被引量:78
  • 4Zhang SH,Reddick RL,Piedrahita JA,Maeda N.Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoproterin E.Science,1992,258:468-471
  • 5Yutaka N,Andrew SP,Elaine WR.ApoE-Deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.Arteriosclerosis Thrombosis,1994,14 (1):133-140
  • 6Chen J,Tung CH,Umar M,Vasilis N,Robert G,Mark C,et al.In vivo imaging of proteolytic activity in atherosclerosis.Circulation,2002,11 (6):2 766-771
  • 7Liischer TF, Landmesser U, yon Eckardstein A, et al. High-densi- ty lipoprotein : vascular protective effects, dysfunction, and potential as therapeutic target [ J ]. Circulation Research, 2014, 114 ( 1 ) : 171-182.
  • 8Dansky HM, Bloomfield D, Gibbons P, et al. Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hyper- cholesterolemia or mixed hyperlipidemia [ J ]. Am Heart J, 2011 , 162(4) : 708-716.
  • 9Kontush A, Chapman MJ. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities[ J]. Curt Opin Lip- idol, 2010, 21(4): 312-318.
  • 10Kotosai M, Shimada S, Kanda M, et al. Plasma HDL reduces non- esterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability [ J ]. Lipids, 2013, 48 ( 6 ) : 569 -578.

共引文献64

同被引文献91

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部